PLEASANTON, Calif., Nov. 2, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Revenue was $153.6 million for the third quarter, a 17%…
